Loading the records…
Loading the records…
HR1867 permanently removes in-person requirements for Medicare mental health telehealth services, providing regulatory certainty for telehealth platforms. $TDOC is up 15.76% over 30 days and $AMWL is up 18.38% over 30 days, reflecting market optimism in the sector. The bill is in early committee stage but has bipartisan sponsorship including Reps. Hern (R-OK) and Suozzi (D-NY), improving passage odds.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
$TDOC at $5.95 (up 15.76% in 30 days) and $AMWL at $6.12 (up 18.38% in 30 days) have already priced in some regulatory optimism, but remain well below highs. Passage of this bill removes a known risk that capped valuations. The market response to actual passage would likely be a 5-10% move for these tickers as the sunset risk is fully eliminated. However, without a companion bill in the Senate yet, near-term catalyst timing remains uncertain.
HR1867, introduced March 5, 2025, in the 119th Congress, amends Section 1834(m)(7) of the Social Security Act to permanently remove the in-person evaluation requirement for Medicare mental health services delivered via telehealth. The bill strikes the sunset date (April 1, 2025) for these flexibilities that were originally tied to the COVID-19 public health emergency. This is a clean, single-purpose bill with no authorized spending—it is a regulatory exemption, not a funding bill. The bill was referred to both Energy and Commerce and Ways and Means committees, indicating jurisdictional overlap on Medicare policy.
The money trail here is indirect but significant. No new money is authorized; instead, the bill removes a regulatory barrier that would have reduced revenue for telehealth providers. Without this bill, Medicare mental health telehealth visits would require an in-person visit within 6 months of the first telehealth visit after the sunset, creating administrative burden and likely reducing patient volume for virtual mental health providers. The Congressional Budget Office would score this as a cost to the Medicare program (more utilization remains), but the mechanism is purely regulatory.
Structural winners are pure-play telehealth platforms: Teladoc ($TDOC) and American Well ($AMWL). Teladoc derives approximately 70% of its revenue from mental health services (BetterHelp + integrated mental health), and Medicare represents a growing share of its US business. American Well's enterprise contracts with health systems depend on Medicare reimbursement stability for their virtual care offerings. Hospitals with in-house telehealth programs (HCA, $HCA; Universal Health Services, $UHS) are indirect beneficiaries, but the impact is smaller relative to their total revenue. Diversified technology companies with telehealth offerings (Amwell's existing platform, not Google or Microsoft) are less impacted since mental health telehealth is a smaller fraction of their business.
Real market data shows the market has already priced in some optimism: $TDOC is up 15.76% over 30 days to $5.95 (52-week range $4.40-$9.77), and $AMWL is up 18.38% to $6.12 (52-week range $3.71-$9.15). Both stocks remain well below their 52-week highs, suggesting the market sees this as a necessary regulatory fix rather than a catalyst that alone returns them to prior highs. The 7-day changes (TDOC +4.39%, AMWL +0.33%) show mixed short-term momentum, possibly reflecting the early legislative stage.
The legislative timeline: HR1867 is in early-stage—referred to two committees with no hearings or markups yet. The bipartisan sponsorship (4 cosponsors including Rep. Suozzi, a Democrat on Ways and Means) improves passage odds in the Republican-controlled House. The bill would need to pass both chambers and be signed by the President. Given the narrow, non-controversial scope (permanent removal of a sunset that most providers already assume will expire), this has a moderate-to-high chance of passing in some form, possibly as part of a larger healthcare extenders package or mental health parity bill.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Regulatory exemption: permanent removal of in-person evaluation requirements for Medicare mental health services delivered via telehealth
Who must act
Centers for Medicare & Medicaid Services (CMS)
What happens
CMS cannot reimpose in-person visit requirements for Medicare mental health telehealth services, ensuring continued reimbursement without geographic restrictions
Stock impact
Teladoc's primary revenue driver is virtual mental health visits; Medicare accounts for ~30% of US telehealth visits. This bill locks in the existing Medicare telehealth mental health reimbursement pathway, removing the 2025 sunset risk that would have required patients to have an in-person visit within 6 months of the first telehealth visit
What the bill does
Regulatory exemption: permanent removal of in-person evaluation requirements for Medicare mental health services delivered via telehealth
Who must act
Centers for Medicare & Medicaid Services (CMS)
What happens
CMS cannot reimpose in-person visit requirements for Medicare mental health telehealth services, ensuring continued reimbursement without geographic restrictions
Stock impact
American Well's telehealth platform supports mental health visits for Medicare beneficiaries; mental health is a core use case for their enterprise contracts with health systems. Removing the in-person requirement sunset maintains the revenue stream from Medicare mental health visits that would otherwise face administrative friction and patient drop-off if in-person visits were required every 6 months
Matched on shared policy language across AI analyses, with ticker & timing weight
Mental Health TALK SAFE Act of 2026
CONNECT for Health Act of 2025
College Students Continuation of Mental Health Care Act of 2025
Second Chance Mental Health Access Act of 2026
Executive orders & memoranda affecting the same sectors or companies
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →